Containment in the Pharmaceutical Industry

Increasing Demands: The Shift in Active Ingredient Development

Over 50% of all newly developed active ingredients today are classified as highly potent substances (HPAPIs) and fall under OEB Level 5 or higher. This means that even the smallest quantities can be toxic – posing risks to personnel, products, and the environment. At the same time, authorities require full GMP compliance and proof that cross-contamination is effectively prevented.

The trend toward smaller batch sizes, flexible multi-product facilities, and increasingly complex molecules requires a fundamental shift in containment strategies. Only those who continuously adapt their protection concepts will remain competitive in the long term.

Balancing Maximum Protection and Economic Productivity

• Contamination remains one of the greatest challenges to occupational safety and product purity.
• Cross-contamination is a major risk, especially in flexible facilities with frequent product changes.
• Interface management continues to be a weak point - every connection between system components carries residual risk.
• Cleaning efforts: Reusable systems result in high costs and time loss due to cleaning and validation.

They key lies in balancing safety, efficiency and flexibility - and that's exactly where modern containment comes in.

A Strategic Crossroad: Traditional Stainless Steel vs. Modern Single-Use Technology

Conclusion: Stainless steel is well-established but inflexible and comes with high ongoing costs.
Single-use technology eliminates cleaning and validation efforts, prevents cross-contamination and enables fast and flexible product changeovers. The higher volume of waste is offset by reduced water and chemical consumption and modern recycling solutions.

Our Approach: Smart Containment Through Flexible Single-Use Systems

Lugaia relies on intelligent, flexible containment solutions that are precisely tailored to the needs of the pharmaceutical industry.

• Maximum flexibility for changing products and processes.
• Guaranteed prevention of cross-contamination
• Major efficiency gains through the elimination of cleaning and faster batch changeovers
• Full compliance with all regulatory requirements (GMP, OEL, FDA, EMA)

Our Solutions at a Glance

• For handling highly potent substances: Our isolator systems
• For dust-free powder transfer: Our TransferBag systems
• For product filling for intermediate and final products: Our Continuous Liner Systems
• For secure connections: Our SafeSeal Closure System
• For meeting the strictest exposure limits: Our OEL expertise

Every solution is modular, scalable and tailored to your specific processes.

Containment is more than a product – it’s a holistic strategy

The best solution starts with dialogue: our experts work closely with you to analyze your processes, risks and goals. Together, we develop a containment concept that not only protects but also enhances your productivity and ensures regulatory compliance.